Periodic Reporting for period 1 - Predictix (Predictix ™ - a user-friendly procedure that analyses genomic, clinical and demographic data to generate a personalized report on the efficacy of antidepressants and their side effects)
Reporting period: 2020-09-01 to 2021-02-28
Applying machine learning methods to the accumulating data derived from Next Generation Sequencing (NGS) technologies, Electronic Health Records (EHR), and sensory devices can transform the way psychiatric disorders are treated.
The PREDICTIX Antidepressant tool was developed out of this growing need for personalized treatment selection for patients diagnosed as suffering from depression. We aspired to create a prediction tool that relies on combinatorial data of clinical, demographic, and genetic information of each patient, in accordance with the applicable literature and guidelines.
The output report, consisting of the likely effectiveness of 11 new-generation antidepressants, will be used to inform clinical decisions in a Clinical Trial for which we finalized the design and we are now seeking regulatory approval.